Company Foresee Pharmaceuticals Co., Ltd.
Equities
6576
TW0006576002
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
84.1 TWD | -0.24% |
|
-0.24% | -12.58% |
Jun. 24 | Foresee Pharmaceuticals Co., Ltd. announced a financing transaction | CI |
May. 14 | Foresee Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drug Development
100.0
%
| 302 | 100.0 % | 195 | 100.0 % | -35.31% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
100.0
%
| 302 | 100.0 % | 195 | 100.0 % | -35.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yu Hua Li
FOU | Founder | - | 15-07-08 |
Benjamin Chien
CEO | Chief Executive Officer | - | 13-02-07 |
Max Chan
DFI | Director of Finance/CFO | 56 | 19-10-06 |
Chief Tech/Sci/R&D Officer | - | 23-04-16 | |
Sheng Lee Yi
CTO | Chief Tech/Sci/R&D Officer | - | 13-01-09 |
Mathieu Boudreau
COO | Chief Operating Officer | - | - |
Wenjin Yang
CTO | Chief Tech/Sci/R&D Officer | - | 15-09-20 |
Bill Miller
LAW | General Counsel | - | 21-05-18 |
David Lau
PRN | Corporate Officer/Principal | - | - |
Jiarong Zhuang
AUD | Comptroller/Controller/Auditor | - | 18-11-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Lee
BRD | Director/Board Member | 73 | 15-08-02 |
Benjamin Chien
CEO | Chief Executive Officer | - | 13-02-07 |
Fu Shiow Yin
BRD | Director/Board Member | - | 16-03-30 |
Kun Hung Lai
BRD | Director/Board Member | - | 18-06-25 |
Wen Chi Lee
BRD | Director/Board Member | - | 16-03-30 |
Chia Lin Wang
BRD | Director/Board Member | - | 16-03-30 |
Chang Jen Yan
BRD | Director/Board Member | - | 13-01-09 |
Sheng Lee Yi
CTO | Chief Tech/Sci/R&D Officer | - | 13-01-09 |
Ben Liu
BRD | Director/Board Member | - | 23-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 135,926,218 | 90,859,218 ( 66.84 %) | 0 | 66.84 % |
Company contact information
Foresee Pharmaceuticals Co., Ltd.
9F-2, No.19-3, Sanchong Road Nangang District
115, Taipei
+
http://www.foreseepharma.com![address Foresee Pharmaceuticals Co., Ltd.(6576)](https://cdn.zonebourse.com/static/address/45304233.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.58% | 351M | |
+16.59% | 44.44B | |
+41.42% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- 6576 Stock
- Company Foresee Pharmaceuticals Co., Ltd.